Invention Grant
- Patent Title: Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
-
Application No.: US16309999Application Date: 2017-06-15
-
Publication No.: US10894793B2Publication Date: 2021-01-19
- Inventor: Didier Jean-Claude Berthelot , Laurence Anne Mevellec , Patrick Rene Angibaud , Sophie Coupa , Christophe Gabriel Marcel Demestre , Lieven Meerpoel , Guillaume Jean Maurice Mercey , Christophe Meyer , Elisabeth Therese Jeanne Pasquter , Isabelle Noelle Constance Pilatte , Virginie Sophie Poncelet , Olivier Alexis Georges Querolle
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Priority: EP16174715 20160616
- International Application: PCT/EP2017/064671 WO 20170615
- International Announcement: WO2017/216292 WO 20171221
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; A61P35/00
Abstract:
The present invention relates to bicyclic pyridine, pyrazine, and pyrimidine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3Kβ inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
Public/Granted literature
- US20190169199A1 BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS Public/Granted day:2019-06-06
Information query
